BeOne Medicines (NasdaqGS:BGNE) Q3 2025 Earnings Call November 06, 2025 08:00 AM ET Company ParticipantsDan Maller - Head of Investor RelationsAaron Rosenberg - CFOXiaobin Wu - President and COOMatt Shaulis - General Manager of North AmericaClara Dong - VP of Biotechnology Equity ResearchJohn Oyler - CEOSean Laaman - Executive Director and Lead US SMID Cap Biotechnology Equity ResearchMark Lanasa - Chief Medical Officer of Solid TumorsYigal Nochomovitz - Director of Biotech Equity ResearchLai Wang - Global ...

BeOne Medicines (NasdaqGS:BGNE) Q3 2025 Earnings Call November 06, 2025 08:00 AM ET Speaker1Good day, everyone. Welcome to BeOne Medicines' Q3 2025 earnings call webcast. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. At this time, I would like to turn the call over to the company.Speaker0Hello and welcome. Thanks for joining us today. I'm Dan Maller, Head of Investor Relations at BeOne Medicines. Before we begin, ...